The largest database of trusted experimental protocols

4 protocols using human il 7

1

Cytokine Production by Cultured ILC2s

Check if the same lab product or an alternative is used in the 5 most similar protocols
Fresh lung ILC2s (CD45+LinCD127+CD90.2+ST2+) sorted from IL33-treated mice were cultured in 96-well round-bottom plates at a density of 5 × 103 cells per well in RPMI-1640 medium containing 10% FCS, 100 U/ml penicillin and 100 mg/ml streptomycin in the presence of 10 ng/ml human IL-2 (PeproTech), 20 ng/ml mouse IL-7 (PeproTech, 217-17-100), 1 ng/ml mouse IL-33 (BioLegend, 580506), 20 ng/ml human IL-7 (R&D Systems, 207-IL-010) and 50 ng/ml human IL-33 (R&D Systems, 3625-IL-010) with or without α-MSH (10 ng/ml) or β-endorphin (MCE, HY-P1502, 10 ng/ml). Then, the levels of cytokines in the culture supernatants were measured by ELISA (mouse IL-5 ELISA kit, Invitrogen, 88-7054-76; mouse IL-13 ELISA kit, Invitrogen, 88-7137-76; human IL-5 ELISA kit, Invitrogen, 88-7056-88; and human IL-13 ELISA kit, Invitrogen, 88-7439-88). For intracellular cytokine staining, 50 ng/ml PMA, 1 µg/ml ionomycin, and 1 µg/ml BFA were added to the cultures 2–4 h before staining.
+ Open protocol
+ Expand
2

Porcine PBMC Expansion with Human and Mouse IL-7

Check if the same lab product or an alternative is used in the 5 most similar protocols
Porcine PBMCs were seeded in 48-well plates and treated with either human IL-7 (R&D system, Minneapolis, MN, USA) or mouse IL-7 (R&D system) at a concentration of 1.6 ng/ml per well. On day 7, the cell culture media was changed and treated with fresh IL-7 at the same concentration, if necessary. The cells were maintained in RPMI 1640 medium containing 10% FBS (Hyclone®) and 1% penicillin/streptomycin (Hyclone®) at 37°C under 5% CO2/95% air.
+ Open protocol
+ Expand
3

HIV-1 Infection and T Cell Activation Assay

Check if the same lab product or an alternative is used in the 5 most similar protocols
HLACs, PBMCs, or SupT1-R5 (106 cells/mL) were mock-treated or infected with F4.HSA at a final concentration of 1500–3000 ng/mL p24Gag, and cultured for 3 days at 37˚C. Where appropriate, primary cells were pre-activated with 10 μg/ml PHA (Sigma) or with Dynabeads Human T-Activator CD3/CD28 (Thermo Fisher), using the appropriate media supplemented with 100 U/mL human interleukin-2 (IL-2) (Life Technologies). To assess infection rates, cells were subjected to flow cytometric analysis as detailed below. For experiments where samples were sorted after infection, cells were first enriched by negative selection for CD4+ T cells using the EasySep Human CD4+ T Cell Enrichment Kit (STEMCELL Technologies) to minimize sort time. Where indicated, sorted cells were mock-treated or stimulated for 2–3 days with Dynabeads Human T-Activator CD3/CD28 (Thermo Fisher) at a ratio of 1 bead/cell in the presence of 60U/ml IL-2 (Life Technologies), 12 nM PEP005 (Ingenol 3-angelate, Sigma-Aldrich), 40 nM Romidepsin (Sigma-Aldrich), or 10 ng/ml human IL-7 (R&D System), and then harvested for flow cytometric analysis as detailed below.
+ Open protocol
+ Expand
4

Quantifying Immune Cell Markers

Check if the same lab product or an alternative is used in the 5 most similar protocols
An FITC-conjugated mouse anti-human CD127 (IL-7Ra) antibody was obtained from BioLegend (San Diego, CA, USA). The PE-conjugated mouse anti-human/mouse CD265 (RANK) antibody was obtained from Thermo Fisher (Rockford, IL, USA). human TGF-b1 ELISA Duo Set and Human TGFBIp ELISA Duo Set were obtained from R&D Systems (Minneapolis, MN, USA). Human RANKL (receptor activator of nuclear factor kappa B ligand) was donated by Eun Ju Chang, PhD (Asan Bio Institute, Seoul, Korea). Human IL-7, human TGF-b1, and human TGFbI protein were obtained from R&D Systems.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!